XML 55 R41.htm IDEA: XBRL DOCUMENT v3.25.0.1
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets and Liabilities Measured at Fair Value
Financial assets and liabilities measured at fair value on a recurring basis are summarized below:
December 31, 2024December 31, 2023
Dollars in millionsLevel 1Level 2Level 3Level 1Level 2Level 3
Cash and cash equivalents
Money market and other securities$— $6,559 $— $— $8,489 $— 
Marketable debt securities
Certificates of deposit— 308 — — 609 — 
Commercial paper— — — — 92 — 
Corporate debt securities— 486 — — 460 — 
U.S. Treasury securities— 39 — — 19 — 
Derivative assets750 — 219 — 
Equity investments247 42 — 318 141 — 
Derivative liabilities— 247 — — 160 — 
Contingent consideration liability
Contingent value rights(a)
— 256 — — 
Other acquisition related contingent consideration— — — — — 
(a)    Includes the fair value of contingent value rights associated with the Mirati acquisition as further described in "—Note 4. Acquisitions, Divestitures, Licensing and Other Arrangements." The fair value of the contingent value rights was estimated using a probability-weighted expected return method.
Summary of Equity Investments Carrying Amount
The following summarizes the carrying amount of equity investments:
December 31,
Dollars in millions20242023
Equity investments with RDFV
$289 $459 
Equity investments without RDFV
863 698 
Limited partnerships and other equity method investments598 542 
Total equity investments$1,750 $1,699 
Schedule of Equity Investments
The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.
Year ended December 31,
Dollars in millions202420232022
Equity investments with RDFV
Net loss recognized
$41 $117 $762 
Less: net loss/(gain) recognized on investments sold
32 (3)(17)
Net unrealized loss/(gain) recognized on investments still held
120 779 
Equity investments without RDFV
Upward adjustments(36)(9)(80)
Net realized (gain)/loss recognized on investments sold(39)— — 
Impairments and downward adjustments62 14 11 
Limited partnerships and other equity method investments
Equity in net (income)/loss of affiliates
(44)38 108 
Total equity investment (gains)/losses
(16)160 801 
Summary of Fair Value of Outstanding Derivatives
The following table summarizes the fair values and the notional values of outstanding derivatives:
 December 31, 2024December 31, 2023
Asset(a)
Liability(b)
Asset(a)
Liability(b)
Dollars in millionsNotionalFair ValueNotionalFair ValueNotionalFair ValueNotionalFair Value
Designated as cash flow hedges
Foreign currency exchange contracts
6,428 424 43 — 4,772 130 1,971 (66)
Cross-currency swap contracts584 26 626 (30)1,210 50 — — 
Designated as net investment hedges
Foreign currency exchange contracts
185 17 — — — — 215 (8)
Cross-currency swap contracts361 23 346 (7)— — 747 (43)
Designated as fair value hedges
Interest rate swap contracts1,500 10 1,955 (20)2,500 1,755 (14)
Not designated as hedges
Foreign currency exchange contracts5,749 250 5,243 (173)906 20 1,250 (29)
Total return swap contracts(c)
— — 443 (17)401 16 — — 
(a)    Included in Other current assets and Other non-current assets.
(b)    Included in Other current liabilities and Other non-current liabilities.
(c)    Total return swap contracts hedge changes in fair value of certain deferred compensation liabilities.
Derivative Instruments
The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedges:
Year Ended December 31,
202420232022
Dollars in millionsCost of products soldOther (income)/expense, netCost of products soldOther (income)/expense, netCost of products soldOther (income)/expense, net
Interest rate swap contracts$— $11 $— $(5)$— $(27)
Cross-currency swap contracts— 67 — (65)— (52)
Foreign exchange contracts(100)(98)(303)(95)(492)(96)
Forward interest rate contracts
— (5)— — — — 

The following table summarizes the effect of derivative and non-derivative instruments designated as hedges in Other comprehensive income/(loss):
Year Ended December 31,
Dollars in millions202420232022
Derivatives designated as cash flow hedges
Foreign exchange contracts gain/(loss):
Recognized in Other comprehensive (loss)/income$418 $13 $592 
Reclassified to Cost of products sold(100)(303)(492)
Cross-currency swap contracts gain/(loss):
Recognized in Other comprehensive (loss)/income(54)57 (7)
Reclassified to Other (income)/expense, net75 (31)(29)
Forward interest rate contract gain/(loss):
Recognized in Other comprehensive (loss)/income131 — — 
Reclassified to Other (income)/expense, net(5)— (3)
Derivatives designated as net investment hedges
Cross-currency swap contracts gain/(loss):
Recognized in Other comprehensive (loss)/income51 52 30 
Foreign exchange contracts gain/(loss):
Recognized in Other comprehensive (loss)/income35 (15)— 
Non-derivatives designated as net investment hedges
Non-U.S. dollar borrowings gain/(loss):
Recognized in Other comprehensive (loss)/income(a)
— (10)91 
(a) In 2023, the Company de-designated its remaining net investment hedge in debt denominated in euros of €375 million, and the amount represents the effective portion of foreign exchange loss on the remeasurement of the debt.